|
|
|
| Therapeutic effect of Shenyuan Yiqi Huoxue Capsules on cerebral thrombosis induced by Punatinib in zebrafish#br# |
| QIN Xiaomei1 GUO Shuaijie1 LI Yue1 LI Sinai1 LIU Weihong1 WANG Xuyun2 LIU Hongxu3 ZHOU Mingxue1▲ |
1.Beijing Institute of Traditional Chinese Medicine, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China; 2.Andrology of Traditional Chinese Medicine, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China;
3.Department of Cardiovascular, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China |
|
|
|
Abstract Objective To study the therapeutic effect of Shenyuan Yiqi Huoxue Capsules (hereinafte referred to as “Shenyuandan Capsules”) on cerebral thrombosis induced by Punatinib in zebrafish. Methods A total of 720 zebrfish were divided into four batches， 180 zebrfish were selected from each batch and placed in a six-well plate with 30 fish in each well. They were divided into six groups: normal control group, model group, positive control group and Shenyuandan Capsules low, middle, and high dose group, which were respectively given fish culture water, Prunatinib, Prunatinib and water-dissolved Aspirin (50 μg/ml) or 55.6, 167.0, 500.0 μg/ml Shenyuandan Capsules. After treatment for 18 h, the number of zebrafish forming cerebral thrombosis was observed; the kinematic velocity of zebrafish was measured by a behavioral analyzer; the blood flow video of zebrafish was recorded by the blood heartbeat analysis software to analyze the blood flow velocity of zebrafish; apoptosis number of brain cells in zebrafish was analyzed by acridine orange staining. Results Compared with model group, the incidence of cerebral thrombosis of zebrafish in Shenyuandan Capsules low, middle, and high dose groups were significantly decreased, and the differences were highly statistically significant (P < 0.01); the kinematic velocity of zebrafish in Shenyuandan Capsules low, middle, and high groups were significantly increased, and the differences were statistically significant (P < 0.01); blood flow velocity of zebrafish in Shenyuandan Capsules medium and high dose groups were significantly increased, and the differences were highly statistically significant (P < 0.01); apoptosis number of zebrafish brain cells in Shenyuandan Capsules high dose group were significantly decreased, and the difference was highly statistically significant (P < 0.01). Conclusion Shenyuandan Capsules can significantly improve the incidence of cerebral thrombosis and kinematic velocity induced by Pratinib in zebrafish, and the mechanism may be related to inhibiting brain cell apoptosis in zebrafish.
|
|
|
|
|
|
[1] 肖明明，李子斌.丹参川芎嗪注射液静脉滴注治疗急性期脑血栓的临床效果分析[J].黑龙江中医药，2020，49（1）：69-70.
[2] 王亚男.优质护理改善脑血栓患者预后的效果研究[J].中国医药指南，2021，19（5）：143-144.
[3] 刘海波.中医治疗脑血栓患者的临床疗效[J].中国医药指南，2020，18（25）：117-118.
[4] 苏军岭.探讨中药活血化瘀法治疗脑血栓的应用效果[J].医学理论与实践，2020，33（21）：3552-3553.
[5] 郭伦聪，庄增辉，庄清芬，等.地黄逐瘀散治疗脑血栓形成的应用及有效性研究[J].中外医疗，2020，39（33）：193-195，198.
[6] 蔡雄辉.中西医结合治疗气虚血瘀型中风（脑血栓形成）[J].中外医学研究，2016，14（4）：34-35.
[7] 尚菊菊，刘红旭，王振裕，等.参元丹胶囊治疗不稳定性心绞痛的临床观察[J].北京中医，2006（2）：67-69.
[8] 孙晴，刘红旭.参元丹治疗冠心病心绞痛络病理论初探[J].北京中医药，2011，30（6）：403-405．
[9] 赵慧，樊华，周端，等.斑马鱼模型在心血管疾病中药筛选和机制研究中的应用[J].中国中医药信息杂志，2018（9）：133-137.
[10] 杨丽玲，余林中.斑马鱼——一种可用于中药抗炎免疫药理研究的模式生物[J].中药药理与临床，2012，28（2）：174-177.
[11] 陈静，赵璐，王毅.模式生物斑马鱼在中药药效物质多模态辨识中的应用[J].中国中药杂志，2020，45（14）：3387-3394.
[12] Li S，Liu H，Li Y，et al. Shen-Yuan-Dan Capsule Attenuates Verapamil-Induced Zebrafish Heart Failure and Exerts Antiapoptotic and Anti- Inflammatory Effects via Reactive Oxygen Species-Induced NF-κB Pathway [J].Front Pharmacol，2021，12：626515.
[13] Zhu XY，Xia B，Ye T，et al. Ponatinib-induced ischemic stroke in larval zebrafish for drug screening [J]. Eur J Pharmacol，2020，889：173292.
[14] 罗彩文.中药益气活血汤治疗脑血栓的临床效果[J].内蒙古中医药，2021，40（2）：9-10.
[15] 迮玉杰.丹参川芎嗪注射液对脑血栓患者血液流变学指标的影响[J].中国实用医药，2021，16（5）：106-109.
[16] Zuurbier SM，Coutinho JM. Cerebral Venous Thrombosis [J]. Adv Exp Med Biol，2017，906：183-193.
[17] 郭永红.缺血性中风气虚血瘀病机学说的理论分析[J].中国民间疗法，2020，28（19）：4-5.
[18] 张敏.丹参川芎嗪注射液治疗脑血栓的临床效果[J].中国当代医药，2020，27（22）：73-75.
[19] 赵步长，伍海勤，赵涛，等.中医脑心同治论[M].北京：人民卫生出版社，2010.
[20] 赵步长，赵明中.“脑心同治”理论指导心脑血管疾病的防治策略[J].中国中西医结合杂志，2013，33（12）：1596-1598.
[21] 刘红旭，金玫，王振裕，等.参元丹煎剂治疗不稳定心绞痛（血瘀证）113例临床观察[J].中医杂志，1999，21（4）：219-221.
[22] 朱雨玫，胡馨，刘红旭.益气逐瘀法对AMI/抑郁大鼠神经体液的影响及其机制研究[J].世界中医药，2017，12（2）：251-253.
[23] Shi X，Verma S，Yun J，et al. Effect of empagliflozin on cardiac biomarkers in a zebrafish model of HF：clues to the EMPA-REG OUTCOME trial? [J]. Mol Cell Biochem，2017，433（1/2）：97-102.
[24] Kim JY，Kim HH，Cho KH. Acute cardiovascular toxicity of sterilizers，PHMG，and PGH：severe inflammation in human cells and HF in zebrafish [J]. Cardiovasc Toxicol，2013，13（2）：148-160.
[25] Huang CC，Monte A，Cook JM，et al. Zebrafish HF models for the evaluation of chemical probes and drugs [J]. Assay Drug Dev Technol，2013，11：561-572.
[26] 李心怡，陈荷清，夏欢，等.蜂胶降脂方对高脂血症模型斑马鱼的降血脂作用研究[J].世界科学技术-中医药现代化，2020，22（5）：1629-1635. |
|
|
|
